Ten years experience in the treatment of Pseudomyxoma peritonei by cytoreduction, peritonectomy and semi-closed hyperthermic antiblastic peritoneal perfusion

Michele De Simone, M. Vaira, A. Caponi, B. Ciaccio, G. Fiorentini, G. Turrisi, L. Ferri, G. Buti

Research output: Contribution to journalArticlepeer-review

Abstract

Background: In the literature good results have been reported for the treatment of Pseudomyxoma peritonei (PMP) by cytoreduction, peritonectomy and hyperthermic antiblastic peritoneal perfusion (H.A.P.P.). Forty-eight patients affected by PMP have been treated with this technique over the past ten years. Patients and Methods: Peritoneal perfusion has been performed with the original semiclosed tecnique after complete surgical cytoreduction in 188 patients affected by peritoneal carcinomatosis. In 48 of the cases the patients were affected from PMP. Aggressive surgical cytoreduction was performed with multiple visceral resections and peritonectomies. Results: Seventeen patients (38%) presented major perioperative complications, and in five cases the reoperation of the patient was required. In spite of this high complication rate, there was no perioperative mortality. The results of the Kaplan-Meier 5- and 10-year survival analysis, were 94% and 82%, respectively, with a disease-free survival of 80% at 5 years and 70% at 10 years. Thirty-nine patients (81.2%) had no evidence of disease at follow-up (range 1-120 months). Discussion: Up to date, the most effective treatment for PMP has been aggressive cytoreduction plus H.A.P.P.

Original languageEnglish
Pages (from-to)725-728
Number of pages4
JournalIn Vivo
Volume20
Issue number6 A
Publication statusPublished - Nov 2006

Keywords

  • Chemotherapy
  • Hyperthermia
  • Peritonectomy
  • Pseudomyxoma peritonei

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Ten years experience in the treatment of Pseudomyxoma peritonei by cytoreduction, peritonectomy and semi-closed hyperthermic antiblastic peritoneal perfusion'. Together they form a unique fingerprint.

Cite this